In breast cancer, extracellular signal-regulated kinase 1 (ERK1) and extracellular signal-regulated kinase 2 (ERK2) phosphorylate WTAP at serine 341 and stabilize WTAP, thus upregulating WTAP protein levels [83]. This evidence concerns the gene MAPK3 and breast carcinoma.